Author: denaeric@gmail.com

California’s Department of Cannabis Control (DCC) announced expanded mandatory Aspergillus testing requirements that will take effect across the licensed cannabis market in 2027. The expansion builds on California’s existing four-species Aspergillus testing mandate and adds new requirements around testing methodology, sample collection protocols, and documentation standards that labs must meet to issue valid compliance results.

What Is Changing

The 2027 requirements will make California’s Aspergillus testing framework one of the most rigorous in the country. Key changes include standardized sample preparation protocols that reduce variability between labs, minimum detection sensitivity thresholds that all licensed testing labs must demonstrate, and enhanced chain-of-custody documentation for Aspergillus samples.

The DCC also announced that it will expand its post-market surveillance testing program, increasing the frequency and geographic distribution of retail sampling for Aspergillus. Operators whose products fail surveillance testing after passing compliance testing will face enhanced regulatory scrutiny and potential suspension of testing relationships with the lab that issued the original passing result.

Why California Is Taking This Step

California’s 2025 recall record drove the DCC’s decision to expand Aspergillus requirements. The state saw a significant increase in Aspergillus-related recalls in 2025, with multiple high-profile brands affected. DCC analysis found that testing methodology inconsistency between labs was a contributing factor in some cases, with different labs producing materially different results for the same product lots.

What Cultivators Should Do Now

The 18-month window between the June 2026 announcement and the 2027 implementation is not as long as it sounds for operators who need to build quality assurance infrastructure from scratch. Cultivators in California should audit their current post-harvest processes for Aspergillus risk points, evaluate post-harvest decontamination options that can reduce baseline spore loads before compliance testing, and ensure their testing laboratory of choice is actively preparing for the expanded requirements.

Operators who wait until 2027 to begin adapting to the new requirements will face a compliance cliff. Those who start now will enter the new regulatory environment with seasoned protocols and tested decontamination systems already in place.

Maine’s cannabis regulatory office issued a recall of pre-rolled cannabis products from NorCO Outdoor Cannabis due to unsafe mold and yeast contamination levels. The recall added to a pattern of Total Yeast and Mold (TYM) failures that have affected Maine’s cannabis market through 2025 and into 2026, with the state recording some of the highest recall rates in the country relative to its market size.

The NorCO Recall Details

The NorCO Outdoor Cannabis recall covered pre-rolled products that had failed to meet Maine’s TYM limits after compliance testing or subsequent regulatory sampling identified unsafe contamination levels. Pre-rolls are a product category that carries particular microbial risk because they incorporate multiple handling steps — grinding, mixing, rolling — that increase the product’s surface area and exposure to environmental contamination between harvest and final packaging.

Maine’s Recall Rate Problem

Maine’s cannabis market has experienced a disproportionate number of mold and yeast recalls for a market of its size. Industry observers have pointed to several contributing factors: the state’s climate creates challenging drying and curing conditions, particularly for outdoor and greenhouse-grown product; the market includes a high proportion of smaller craft cultivators with less sophisticated post-harvest infrastructure; and the state’s regulatory office has been relatively aggressive in pursuing surveillance testing that catches contamination issues that might otherwise go undetected.

The combination of challenging growing conditions and active regulatory oversight creates a compliance environment where cultivators cannot afford to rely on favorable weather or minimal quality control protocols.

Pre-Rolls and Microbial Risk

The NorCO recall highlights a compliance risk specific to pre-rolls and similar processed flower products. When raw flower is ground for rolling, the total surface area exposed to air, equipment surfaces, and handler contact increases dramatically. Any mold spores or bacteria present in the facility, on equipment, or on handlers’ hands have more opportunity to colonize the product.

Cultivators who produce pre-rolls should treat the grinding and rolling process as a critical control point for microbial management, with decontamination of equipment between batches, environmental monitoring, and where appropriate, application of decontamination treatment to ground material before rolling.

When a cannabis recall is announced, the immediate conversation focuses on the destroyed inventory: how many pounds, how many units, what was the wholesale value. These numbers are real and painful. But cultivators who have lived through a recall know that destroyed inventory is only the beginning of the financial reckoning.

Direct Costs

Destroyed inventory is the most visible cost, but several other direct costs accompany every recall. Logistics costs to retrieve product from retail partners and transport it to a destruction facility are significant, particularly for operators with broad distribution. Destruction fees, which vary by state and method, add additional cost. Regulatory filing requirements and the administrative burden of recall coordination consume staff time that could otherwise be generating revenue.

In some states, recalls trigger mandatory facility inspections that can result in additional citations, fines, or temporary suspension of operations. The cost of regulatory remediation — hiring consultants, implementing corrective action plans, documenting improvements — can exceed the direct inventory loss for operators with systemic quality issues.

Indirect Costs

The indirect costs of a recall are harder to quantify but often larger than the direct ones. Retail relationships take damage that may be permanent. Dispensary buyers who experience the operational disruption of a recall often reduce or eliminate orders from the operator going forward. The reputational impact with consumers — particularly in markets where brand loyalty is a differentiator — can be significant and long-lasting.

For brands operating in competitive markets, a recall creates an opening for competitors to capture shelf space and consumer loyalty that is difficult to reclaim. Marketing investment required to rebuild consumer confidence after a recall can be substantial.

Prevention Economics

Against the full cost picture of a recall, the economics of post-harvest decontamination technology look very different than they do compared only to the direct cost of a failed compliance test. A single avoided recall typically covers multiple years of preventive technology investment. For operators who experience repeat compliance failures, the case for prevention investment is overwhelming. The question is not whether prevention pays — it clearly does. The question is whether to learn that lesson before or after a recall.

Missouri’s Division of Cannabis Regulation announced a recall of Sinse Prepackaged Flower after state surveillance testing identified Aspergillus mold contamination in product lots that had already cleared compliance testing and entered the licensed retail market. The recall was issued in partnership with the cultivator, Sinse Cultivation Cherokee LLC.

How the Contamination Was Discovered

The Missouri recall illustrates an important but often underappreciated element of cannabis compliance systems: state surveillance testing. Unlike compliance testing submitted by operators before products reach the market, surveillance testing is conducted by or on behalf of regulators on products already on retail shelves. It serves as an independent check on the integrity of the compliance testing system.

In the Sinse case, products that had received passing compliance test results were subsequently identified as Aspergillus-positive when state regulators collected and tested retail samples. This created a significant problem for the operator: products that had been sold to consumers on the basis of a passing COA were now the subject of a public recall.

The Aspergillus Problem in Missouri

Missouri has experienced a pattern of Aspergillus-related recalls that mirrors trends in other regulated cannabis markets. The state’s Division of Cannabis Regulation has been increasingly active in both compliance oversight and public recall notifications, signaling a more aggressive regulatory posture toward microbial contamination.

For Missouri cultivators, the Sinse recall should reinforce that passing a compliance test is not a permanent guarantee of product safety. Products can be re-tested by regulators at any point during their retail life, and a result that differs significantly from the original COA creates serious liability.

What the Sinse Recall Teaches

The most effective protection against surveillance testing failures is the same as protection against compliance testing failures: ensuring that product is genuinely clean before it leaves the facility. Cultivators who implement post-harvest decontamination create products with lower baseline microbial loads that are more likely to pass both initial compliance testing and any subsequent regulatory sampling.

Potency inflation has been a poorly-kept secret in the cannabis industry for years. The incentive is straightforward: consumers and dispensaries gravitate toward higher THC numbers, and some testing laboratories have historically provided them — either through legitimate analytical variation or through deliberate manipulation. In 2026, regulators are running out of patience with this problem.

The Potency Audit Crackdown

Multiple states have implemented or announced mandatory potency audit programs that require licensed cannabis testing laboratories to submit to independent verification of their potency testing results. These programs typically involve regulators collecting product samples at retail and submitting them to reference laboratories for comparison against the COA values on the packaging.

When retail samples consistently test significantly below the COA-stated THC percentage, regulators treat that as evidence of potential potency inflation at the original testing laboratory. Labs identified as outliers face investigation, enhanced oversight, or loss of licensing.

Why Potency Inflation Matters Beyond Marketing

The potency inflation problem is not just a consumer protection issue around accurate labeling. Systematic potency inflation by testing laboratories distorts the entire compliance testing ecosystem. If a lab is willing to inflate THC numbers, questions arise about what else they might be manipulating. The Michigan and New York lab fraud cases that involved Aspergillus result falsification both occurred at labs that were also suspected of potency result manipulation.

Potency inflation and mold result manipulation are different expressions of the same underlying problem: a lab willing to report results that benefit clients at the expense of accuracy. Cultivators who are knowingly using labs that inflate potency are taking on compounding compliance risks.

The Path Forward

Cultivators who have relied on inflated potency numbers as a competitive differentiator need to prepare for a market where that advantage disappears. The 2026 potency audit crackdown will ultimately create a more accurate potency landscape, which means consumer and buyer expectations will recalibrate. Investing in quality genetics, cultivation technique, and post-harvest practices that genuinely optimize cannabinoid content is the sustainable path forward.

When cannabis cultivators investigate the root cause of a TYM or Aspergillus compliance failure, the conversation often focuses on the grow room: humidity levels during flowering, airflow, plant density. These are important factors. But industry data increasingly points to the post-harvest window — drying, curing, trimming, and storage — as the period when many microbial contamination problems actually take hold or escalate.

Why Post-Harvest Is the Critical Window

At harvest, cannabis flower has a relatively high moisture content. As it dries, the water activity of the flower decreases to a level where most microbial growth slows significantly. But the path from harvest moisture levels to stable dried flower water activity passes through a window where conditions can be ideal for mold colonization if temperature and humidity are not carefully managed.

Mold spores are ubiquitous in any agricultural environment. They are present on surfaces, in the air, and on the plant material itself. Under the right conditions of warmth and moisture, those spores can germinate and begin colonizing flower within hours. A drying room that is too humid, a trim facility without adequate climate control, or a curing vessel that traps moisture can all create those conditions.

Packaging as a Contamination Vector

One factor that is often overlooked is packaging. Cannabis flower that meets moisture content targets at the time of packaging can still develop mold problems if humidity migrates into the package after sealing. This is particularly common with products that pass through multiple temperature environments during distribution — from a climate-controlled warehouse to a delivery vehicle to a retail storage room — each transition can create condensation conditions inside packaging.

Industry observers note that microbials can grow on products that were clean when packaged if humidity increases after storage or if packaging is inadequate for the distribution environment.

Proactive Solutions

The most effective approach combines environmental control with proactive decontamination. Maintaining drying and curing environments within tight temperature and humidity ranges reduces the window for mold colonization. Post-harvest decontamination treatment applied before final packaging reduces the microbial load entering the package. Together, these measures provide the most robust protection against the humidity-driven mold failures that continue to generate compliance losses across the industry.

ISO 17025 is the international standard for testing and calibration laboratory competence. It sets requirements for the management systems, technical operations, and staff competence of laboratories that perform testing across any industry. In 2026, a growing number of state cannabis regulators are making ISO 17025 accreditation a mandatory requirement for laboratories authorized to issue compliance test results for licensed cannabis products.

What ISO 17025 Actually Requires

ISO 17025 accreditation is not a certificate that labs can obtain by filling out a form. Achieving and maintaining accreditation requires laboratories to demonstrate documented management systems, validated testing methods with uncertainty quantification, equipment calibration traceable to national standards, staff training and competency verification, and participation in proficiency testing programs.

Critically, accredited labs must participate in inter-laboratory comparisons where they analyze identical blind samples alongside other accredited labs. Significant outliers in these comparisons trigger investigation and can result in suspension or revocation of accreditation. This mechanism is specifically designed to catch the kind of systematic result manipulation that has characterized recent cannabis lab fraud cases.

How This Helps Cultivators

For cannabis cultivators, the spread of ISO 17025 requirements in 2026 is good news. It means the lab infrastructure that produces compliance test results is being held to a validated, internationally recognized standard rather than ad hoc state licensing criteria that vary widely in rigor.

Cultivators operating in states that have implemented ISO 17025 requirements can have greater confidence that their COAs reflect actual analytical results. The standard does not eliminate the possibility of fraud, but it makes sustained, systematic manipulation significantly harder to execute without detection.

Selecting a Lab in 2026

Cultivators should verify ISO 17025 accreditation status when selecting a testing laboratory, even in states that do not yet require it. Accreditation status is publicly verifiable through the accrediting body. Choosing an accredited lab is one practical step cultivators can take to reduce their exposure to the kind of lab fraud risks that generated recalls in New York and Michigan.

Alien Labs, one of California’s most prominent and well-regarded cannabis brands, became the subject of a mandatory recall when the state’s Department of Cannabis Control (DCC) ordered the pullback of multiple flower and pre-roll product lots due to Aspergillus spp. contamination. The recall was a stark reminder that brand reputation and market position do not confer immunity from microbial compliance failures.

The Recall Details

The DCC issued the mandatory recall notice for multiple Alien Labs flower and pre-roll product lines after compliance testing identified the presence of Aspergillus species in product lots that had already entered the licensed distribution network. Affected products were required to be pulled from retail shelves and destroyed.

For Alien Labs, a brand known for premium genetics and strong consumer loyalty, the recall represented significant economic and reputational exposure. Products had to be retrieved from retail partners across the state, destroying inventory value at every stage of the supply chain.

Why Premium Brands Are Not Protected

A common assumption in the cannabis market is that premium-tier operators have more rigorous quality control than mid-market or value brands. The Alien Labs recall challenges that assumption. Aspergillus contamination does not discriminate based on price point or brand positioning. It is an environmental and agricultural challenge that affects any operation that does not actively address post-harvest microbial risk.

Cannabis flower that is grown, harvested, dried, and cured without post-harvest decontamination treatment carries a baseline microbial load that reflects its agricultural origins. Whether that load exceeds compliance thresholds depends on environmental factors that can shift between harvests, making contamination risk inherently unpredictable without active mitigation.

Protecting Premium Product Quality

For operations like Alien Labs that have invested heavily in genetics, cultivation technique, and brand identity, protecting that investment through post-harvest decontamination is not a compromise of quality — it is an extension of the quality commitment. Proactive microbial reduction before compliance testing protects product from failures that would otherwise undo months of cultivation investment.

In one of the most consequential lab fraud cases in the history of regulated cannabis in the United States, New York’s Office of Cannabis Management announced a recall of cannabis products from 54 lots after a records audit revealed that Keystone State Testing New York had issued unreliable test results for Aspergillus contamination.

What the Investigation Found

An OCM inspection and records audit conducted between December 2025 and January 2026 found that Keystone State Testing had falsely reported products as passing Aspergillus testing when the products did not actually meet New York’s safety standards. An additional product lot was found to have an incorrectly reported result for cadmium, a heavy metal.

The OCM determined that the unreliable results were not random errors. The pattern of falsification suggested a systemic problem with how Keystone was conducting and reporting Aspergillus testing for adult-use cannabis products in New York’s licensed market.

The Scope of the Recall

54 product lots is an enormous number for a single lab fraud case. These products had been distributed through New York’s licensed adult-use retail network and had reached consumers on the basis of test results that regulators now deemed unreliable. The OCM issued public recall notices and worked with licensed retailers to pull affected products from shelves.

For the brands whose products were included in the recall, the damage extended far beyond the immediate economic hit of destroyed inventory. Consumer trust, retailer relationships, and brand reputation all took damage as a result of a third-party testing failure entirely outside the brands’ control.

The Systemic Lesson

The Keystone case illustrates a painful reality for cannabis cultivators: your product’s compliance status is only as good as the integrity of the lab that tests it. A cultivator who grew clean, properly dried and cured flower can still end up in a recall if their testing lab provides fraudulent results. The only way to break this dependency is to build quality assurance systems that establish the cleanliness of product independently of the third-party test — through proactive decontamination, internal monitoring, and rigorous documentation of the post-harvest process.

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!